Darin Lippoldt insider trades
Open-market stock purchases and sales by Darin Lippoldt, Chief Legal Officer at Neurocrine Biosciences Inc, from SEC Form 4 filings since Feb 15, 2011.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 11, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Sep 11, 2026 | NBIX Neurocrine Biosciences Inc | Sold (not open market) | $378K |
| Jul 9, 2026 | NBIX Neurocrine Biosciences Inc | Sold | $1.8M |
| Jul 9, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Jun 29, 2026 | NBIX Neurocrine Biosciences Inc | Sold | $1.4M |
| Jun 29, 2026 | NBIX Neurocrine Biosciences Inc | Sold | $289K |
| Jun 29, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Jun 29, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Jun 26, 2026 | NBIX Neurocrine Biosciences Inc | Sold | $33.9K |
| Jun 26, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Sold (not open market) | $140K |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Sold (not open market) | $668K |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Sold (not open market) | — |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Sold (not open market) | $135K |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Feb 12, 2026 | NBIX Neurocrine Biosciences Inc | Sold (not open market) | $119K |
| Feb 12, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Jan 31, 2026 | NBIX Neurocrine Biosciences Inc | Sold (not open market) | $182K |
| Jan 31, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Jan 8, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Dec 8, 2025 | NBIX Neurocrine Biosciences Inc | Sold | $699K |